Argus
•
Sep 13, 2023
ENTA: Lowering target price to $10.00
Summary
Enanta Pharmaceuticals Inc is an American biotechnology company focused on the research and development of molecule drugs to cure viral infections and liver diseases.
Upgrade to begin using premium research reports and get so much more.
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
UpgradeRelated Reports
PTCT: Lowering target price to $67.00
Sep 02, 2026
•
PTCT
ANIP: Lowering target price to $68.00
Sep 02, 2026
•
ANIP
COLL: Lowering target price to $23.00
Sep 02, 2026
•
COLL
SUPN: Lowering target price to $42.00
Sep 02, 2026
•
SUPN
XNCR: Lowering target price to $29.00
Sep 02, 2026
•
XNCR
